R&D and Tech
Investing in R&D-intensive markets is our expertise. Our meticulous evaluation of various sectors and tireless scouting activities allow us to select strategic assets in innovation clusters in the US real estate market, generating real opportunities for repositioning and value creation on the assets.
A Stars and Stripes strategy
Our investment proposals are in the form of closed-end real estate funds reserved for qualified investors, managed by Arsenale RE SGR, an entity regulated by the Bank of Italy (Banca d’Italia) and CONSOB and compliant with the European AIFMD directive. The AREUS I Strategy is dedicated to investments in the redevelopment of real estate for R&D, Creative, Media and Laboratory use in innovative clusters in the United States of America:
– Boston, MA – World leader in biotech research
– Silicon Valley, CA – Home of the tech giants
– Los Angeles – Media and entertainment capital of the world
– Other rapidly expanding markets, such as San Diego (CA) and Austin (TX).
Investing where the
future begins
In the last 20 years, the growth of the high-tech broke all records compared to any other sector. With AREUS I we create cutting-edge spaces that directly address to high-tech and innovative companies.
“We respond to the business needs of creative start-ups, which attract top talent, have high productivity and grow very quickly, which also leads them to grow in terms of physical space.
In such a context, our real estate investments have proven to be strategic in generating higher returns.”
Facilities designed to attract
Hi-tech companies in the United States are built around education hubs of very high level. These are contexts in which, in order to attract and retain the best talent, offering stimulating work environments is necessary. Food halls, gyms, large and flexible open spaces: innovative companies need spaces that are different from the usual offices. The world’s largest and most important companies operate in these creative spaces, providing investors with higher returns than in traditional business environments. In addition, the creation of laboratories and research areas also allows us to attract the interest of pharmaceutical and medical companies, sectors that are growing exponentially and are highly resistant to economic cycles.
